Please sign in to follow a disease.

B-cell lymphomas

Clinical trials for B-cell lymphomas explained in plain language.

Never miss a new study

Get alerted when new B-cell lymphomas trials appear

Sign up with your email to follow new studies for B-cell lymphomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy aims to boost remission in Hard-to-Treat lymphoma

Disease control Not yet recruiting

This phase 2 trial tests whether a combination of the targeted drug glofitamab with chemotherapy (gemcitabine and oxaliplatin) can improve the effectiveness of a CAR-T cell therapy called lisocabtagene maraleucel in people with relapsed or refractory aggressive B-cell lymphomas. …

Matched conditions: B-CELL LYMPHOMAS

Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

B-cell lymphomas

Get alerted when new B-cell lymphomas trials appear

New combo therapy aims to boost remission in Hard-to-Treat lymphoma